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Summary An experiment examined whether and how the relationship between individual
differences in social attachment and cooperation is modulated by brain oxytocin, a neuropeptide
implicated both in parent—child bonding, and in social approach. Healthy males completed a
validated attachment style measure, received intranasal oxytocin or placebo, and privately chose
between cooperation and non-cooperation in an incentivized social dilemma with an anonymous
stranger. Attachment anxiety-the tendency to fear rejection by others-had few effects and was
not modulated by oxytocin. However, oxytocin interacted with attachment avoidance-the
tendency to fear dependency and closeness in interpersonal relations. Especially among parti-
cipants high rather than low in attachment avoidance, oxytocin reduced betrayal aversion, and
increased trust and cooperation compared to placebo. Effects of attachment avoidance and
oxytocin on cooperation were mediated by betrayal aversion, and not by affiliation tendencies.
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1973). In adulthood, differences in acquired cognitive-emo-
tional schemas position an individual on two broad attach-
ment dimensions — attachment anxiety and attachment
avoidance (Mikulincer and Florian, 1995; Van IJzendoorn,
1995; Collins, 1996; Lemay and Dudley, 2011). Attachment
anxiety provides a cognitive-emotional model about the self,
such that individuals higher on attachment anxiety are
chronically worried about being rejected and unloved.
Attachment avoidance, in contrast, provides a model about
others, such that individuals lower on attachment avoidance
feel they can depend on others to be available when needed,
and are comfortable with closeness and intimacy. Attach-
ment avoidance forms the basis for the regulation of affect
vis-a`-vis others, and for (lack of) social approach. Although
1 It is precisely these two motives — greed and fear — that operate
in a wide range of social decision making settings, from volunteers in
community service to financial traders, from partners sharing a
household to soldiers teaming up to fight the enemy, and from
colleagues in work organizations to high-ranking consultants prepar-
ing a hostile take-over (Komorita and Parks, 1995).
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pendently, both need to be low for an individual to have a so-
called secure rather than insecure attachment style (Collins,
1996; Fraley and Shaver, 2000). Secure attachment associates
with trust in others, and enables people to develop stable
relationships with others (Mikulincer and Shaver, 2007).
What we now call attachment may have arisen from
physiological solutions to simpler problems related to survi-
val and reproduction (Uvnas-Moberg, 1998; Bartz et al.,
2010a). Mammalian reproduction requires a particularly
intense investment of time and energy, and in humans and
some other mammals, involves a commitment to a specific
infant. Accordingly, the association between reproduction
and social bonding may have contributed, in an evolutionary
sense, to the selection of neurochemical systems involved in
attachment behaviors (Carter, 1998; Young et al., 2001). One
such neurochemical is oxytocin, a nine amino-acid, cyclic
neuropeptide produced in the hypothalamus and released
into the blood stream from axon terminals and into the brain
from dendrites of hypothalamic neurons (Donaldson and
Young, 2008; Heinrichs et al., 2008). Oxytocin’s targets
include the amygdala, hippocampus, and regions of the spinal
cord that regulate the parasympathic branch of the auto-
nomic nervous system (Ludwig and Leng, 2006; Neumann,
2008; Roderigues et al., 2009). Oxytocin interacts with the
hypothalamic—pituitary—adrenal axis to attenuate stress
responses (Uvnas-Moberg, 1998; Heinrichs et al., 2003; Kirsch
et al., 2005; Neumann, 2008), with dopaminergic, reward
processing circuits in the nucleus accumbens shell and in the
ventral tegmental area (Skuse and Gallagher, 2005), and with
brain areas involved in the development of empathy such as
the inferior frontal gyrus and ventromedial prefrontal cor-
text (Baumgartner et al., 2009; Hurlemann et al., 2010; Riem
et al., 2011; Shamay-Tsoory, 2011).
Several studies suggest a role for oxytocin in adult attach-
ment formation and maintenance. Plasma oxytocin nega-
tively relates to attachment anxiety and avoidance (Tops
et al., 2007), and intranasal oxytocin compared to placebo
lowers post-test attachment avoidance in insecurely
attached males (Buchheim et al., 2009). Furthermore, there
is a clear role for oxytocin in the development of parent—
child attachment. Intranasally administered oxytocin (versus
placebo) made fathers more stimulating of their child’s
exploration (Naber et al., 2010), and activated neural cir-
cuitries related to empathy in women exposed to infant
crying (Riem et al., 2011). In naturalistic settings, Feldman
et al. (2007) showed that plasma oxytocin during pregnancy
and postpartum predicted maternal bonding behaviors (e.g.,
gaze, vocalizations, positive affect), affectionate touch, and
attachment-related thoughts. Gordon et al. (2010) added to
this that paternal oxytocin levels correlated with the degree
of stimulatory parenting behaviors (e.g., proprioceptive con-
tact, tactile stimulation, and object presentation), and Feld-
man et al. (2010) showed that parental and infant oxytocin
levels were correlated and these related, in turn, to greater
affect synchrony and infant social engagement.
In addition to mediating parent—child attachment forma-
tion and maintenance, oxytocin also interacts with adult
attachment style. Compared to mothers with insecure attach-
ment, those with secure attachment (classified as low on both
attachment anxiety and avoidance) had greater activation in
the ventral striatum and the medial prefrontal cortex whenexposed to pictures of toddlers, and activity in these reward
processing regions correlated with blood plasma oxytocin
(Strathearn et al., 2009). Along similar lines, intranasal oxy-
tocin increased positive memories about maternal care among
low attachment anxiety adults, and increased negative mem-
ories about maternal care among high attachment anxiety
individuals (Bartz et al., 2010a). Apparently, especially for
securely attached individuals, both positive and negative
affective cues related to their infant and/or childhood may
act as an incentive signal, reinforcing and motivating (working
models of) responsive maternal care.
The intimate interplay between feelings of attachment,
oxytocin, and bonding, opens up the possibility that oxytocin
interacts with feelings of attachment in predicting social
cognition, motivation, and behavioral tendencies in encoun-
ters with non-family protagonists such as colleagues, custo-
mers, teammates, bystanders, and passersby-all those we
know little about yet whose behaviors influence our outcomes
and our behavioral actions affect theirs. Such social interac-
tions can be modeled as a social dilemma, in which two (or
more) individuals simultaneously decide to cooperate or not
with their protagonist. The dilemma occurs because mutual
cooperation leads to better payoffs to individual and prota-
gonist than mutual non-cooperation, but unilateral non-coop-
eration generates higher personal payoff than unilateral
cooperation. Accordingly, in this social dilemma, and the many
social exchange settings it models, failure to cooperate is due
to (i) the greedy desire to exploit the protagonist’s possible
cooperative choice or (ii) betrayal aversion, or the fear of
being exploited by the protagonist’s non-cooperative choice
(Coombs, 1973; Komorita and Parks, 1995).1
Whereas there is little reason to assume attachment
anxiety and/or avoidance to predict greed, both attachment
anxiety and avoidance may be related to betrayal aversion.
Attachment anxiety may be related to betrayal aversion
because of the chronic feeling that one is unworthy of other’s
cooperativeness (Bartz et al., 2010b). Attachment avoidance
may be related to betrayal aversion because of the chronic
feeling that one cannot depend on others. Especially the
latter feeling may be susceptible to modulation by oxytocin.
In general, oxytocin reduces betrayal aversion (Kosfeld et al.,
2005; Baumgartner et al., 2008; De Dreu et al., 2010), and
approach motivation (Kemp and Guastella, 2011). Provided
protagonists are not depicted as untrustworthy or competi-
tive, oxytocin promotes behavioral expressions of trust
(Mikolajczak et al., 2010; also see Kosfeld et al., 2005;
DeClerck et al., 2010), and tendencies to affiliate (Kemp
and Guastella, 2011; De Dreu et al., 2011a, 2011b). Together
with its general anxiolytic effects (Heinrichs et al., 2008),
oxytocin thus reduces betrayal aversion and increases affilia-
tion tendencies, and this should be particularly so among
individuals with higher attachment avoidance.
The above suggests three hypotheses. Hypothesis 1 is that
oxytocin increases cooperation especially among individuals
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cially among individuals with higher attachment avoidance,
oxytocin (2a) increases trust and lowers betrayal aversion, and
(2b) strengthens affiliation tendencies. Finally, Hypothesis 3 is
that the moderating effect of oxytocin on the attachment
avoidance — cooperation relationship is mediated by (3a)
betrayal aversion and/or (3b) affiliation tendencies.
2. Methods and materials
2.1. Overview
Hypotheses were tested in a double-blind, placebo-con-
trolled between-subjects design in which healthy males
completed validated measures of attachment anxiety and
avoidance,2 received intranasal oxytocin or placebo, and
made three private choices between cooperation and non-
cooperation towards an unknown protagonist who also
decided between cooperation and non-cooperation. Decision
making had financial consequences. Following decision mak-
ing, participants reported their betrayal aversion, affiliation
tendencies, mood states, and indicated their (post-test)
attachment style.
2.2. Subjects
The experiment was approved by the University ethics com-
mittee, and participants provided informed consent prior to the
experiment. Males (N = 77; M = 20.81 years) received s10 for
participation, and earnings from the decision task. Exclusion
criteria were medical or psychiatric illness, prescription-based
medication, smoking more than five cigarettes per day, and
drug or alcohol abuse. Participants were instructed to refrain
from smoking or drinking (except water) for 2 h before the
experiment. All sessions took place between noon and 4 PM.
2.3. Test medication
Participants self-administered a single intranasal dose of
24 IU oxytocin (Syntocinon-Spray, Novartis; 3 puffs per nos-
tril, each with 4 IU oxytocin) or placebo 35 min before the
start of the experiment. The placebo contained all the active
ingredients except for the neuropeptide, and was prepared
adhering to the European Union GMP and GCP guidelines.
2.4. Procedure, measures, and tasks
Participants were seated in individual cubicles so they could
neither see nor communicate with others, signed an informed
consent, and self-administered the medication (placebo or
oxytocin, double-blind randomized) under experimenter
supervision. The experimenter left and participants com-
pleted unrelated tests. Effects of oxytocin plateau approxi-
mately 30—40 min after administration (Baumgartner et al.,2 Attachment anxiety was measured and included in all analyses to
explore possible interactions between attachment anxiety and treat-
ment, and to examine whether effects of attachment avoidance
depend on levels of attachment anxiety (e.g., Bartz et al., 2010b).2008). Accordingly, after 35 min the computer switched to
the experimental task. Participants read instructions, keyed
in responses, and then were fully debriefed, paid, and dis-
missed.
Prior to the laboratory experiment, participants com-
pleted a test battery that included the revised 18-item Adult
Attachment Style questionnaire (AAS; Collins, 1996). Ratings
on the 12 items assessing attachment avoidance (i.e., fear of
closeness and fear of dependency) were averaged into one
index (Cronbach’s a = 0.84); ratings on the 6 remaining items
were averaged into an index of attachment anxiety (Cron-
bach’s a = 0.78) (all items 1 = not at all to 5 = very strong).
Attachment avoidance correlated with attachment anxiety
(r = 0.398, p < .001).
The experimental task involved an incentivized social
dilemma. Each participant was randomly paired to another
participant present in another cubicle, and informed that
decisions would remain anonymous. Participants were told
that they and the other individual would simultaneously and
without communication choose between A (denoting coop-
eration) and B (denoting non-cooperation), that the combi-
nation of own and other’s choice would determine each
person’s payoff, and that financial earnings would be paid
at the end of the experiment. A table showed that joint
cooperation (AA; s3 to each individual) yielded more than
joint defection (BB; s1 to each individual), but unilateral
cooperation (AB; s0 to the cooperating individual) yielded
lowest, and unilateral defection (BA; s4 to the defecting
individual) yielded highest outcomes. Non-cooperation here
is driven by the desire to avoid s0 (fear, distrust) and/or the
desire to obtain s4 (greed; Coombs, 1973; De Dreu et al.,
2010).
Following instructions, participants were quizzed about
their understanding of the task. Specifically, for each
possible combination of choices participants were asked
to indicate their earning, and that of their partner. Follow-
ing each answer, the correct answer was displayed and
participants moved on with the next quiz-question. Ana-
lyses of participants’ answers revealed that no participant
made more than one error, and errors were never made in
the last and before last question. From this it is concluded
that participants understood the social dilemma. Following
the quiz, participants were told that they would be asked
several times to make a choice between A and B, and that
one of their decisions would be randomly selected for
actual pay. It was clarified that for all decisions they were
paired with the same partner, and that no feedback about
other’s decisions would be provided. Decision making was
self-paced, with random waiting time of 10—30 s in
between decision prompts. In total, participants were
asked three times to make a choice–—cooperation thus
ranges from 0 to 3.
In addition to cooperation, the experiment assessed a
number of other dependent variables with a post-task
questionnaire (all items 1 = not at all to 5 = very much).
Trust was assessed with three items (‘‘I expected the other
player to choose Option A’’ [the cooperative choice]; ‘‘I
trusted the other player was motivated to seek good out-
comes for both of us,’’ and ‘‘I felt the other player could
not be relied upon’’ [reverse coded]; Cronbach’s a = 0.87).
The related construct of betrayal aversion was measured
with two items (‘‘During decision making I tried to
Table 1 Descriptive statistics and zero-order correlations for all dependent variables.
M SD 2. 3. 4. 5. 6. 7. 8. 9. 10.
1. Attachment Anxietya 3.24 0.59 0.39 ** 0.14 0.12 0.02 0.11 0.01 0.01 0.04 0.14
2. Attachment Avoidancea 4.14 0.53 0.03 0.22 * 0.27 * 0.01 0.23 * 0.20# 0.21# 0.05
3. Treatmentb 0.53 0.50 0.08 0.06 0.06 0.06 0.08 0.06 0.03
4. Cooperation 1.17 1.18 0.63 ** 0.07 0.52 ** 0.09 0.04 0.02
5. Trust 2.68 1.01 0.08 0.37 ** 0.10 0.23 * 0.08
6. Affiliation 1.97 0.81 0.13 0.11 0.05 0.05
7. Betrayal Aversion 3.36 1.09 0.02 0.23 * 0.01
8. Feeling at Ease 3.71 0.53 0.11 0.53 **
9. Hostility 1.45 0.66 0.01
10. Happy 2.71 0.70
a Attachment anxiety and avoidance are coded from low (1) to high (5).
b Treatment is dummy coded with 0 = placebo and 1 = oxytocin.
# p < 0.10 (two-tailed, with N = 77).
* p < 0.05 (two-tailed, with N = 77).
** p < 0.01 (two-tailed, with N = 77).
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the other would exploit me;’’ r[77] = 0.67). Affiliation ten-
dency was assessed with three items (‘‘I think it’ll be fun to
do another task with this partner,’’ ‘‘I feel my partner and I
have a lot in common,’’ and ‘‘I feel connected to my part-
ner;’’ Cronbach’s a = 0.84), and how calm/at ease, hostile,
and happy they felt (each three items, Cronbach’s a > 0.73).
Finally, to examine whether treatment influences attach-
ment (Buchheim et al., 2009), participants were presented
with Hazan and Shaver’s (1987) scenarios that briefly
describe the prototypical secure, anxious, and avoidant
attachment style (HS-Secure ‘‘I find it relatively easy to
get close to others and am comfortable depending on them,
and having them depend me. I don’t often worry about being
abandoned or about someone getting too close to me;’’ HS-
Anxious: ‘‘I find that others are reluctant to get as close as I
would like. I often worry that my partner doesn’t really love
me or won’t stay with me. I want to merge completely with
another person, and this desire sometimes scares people
away;’’ HS-Avoidant: I am somewhat uncomfortable being
close to others; I find it difficult to trust them completely,
difficult to allow myself to depend on them. I am nervous
when anyone gets too close, and often, love partners want
me to be more intimate than I feel comfortable being.’’).
Participants indicated which scenario best described
themselves.33 The Adult Attachment Scale ratings for attachment security and
attachment anxiety predicted the choice of Hazan and Shaver’s
(1987) scenarios. Those selecting the Secure Scenario (N = 49)
reported lower attachment avoidance on the AAS than those select-
ing the Anxious (N = 11) or Avoidant (N = 17) Scenarios (M = 4.313 vs.
M = 1.929 and 3.221, F(2,74) = 17.632, p < 0.001. Vice versa, those
selecting the Anxious Scenario rated higher on attachment anxiety
on the AAS (M = 2.653) than those selecting the Secure and Avoidant
Scenarios (M = 1.929, and M = 2.091), F(2,75) = 7.477, p < 0.001.
These results provide converging validity to the Adult Attachment
Scale measure used in the below analyses.3. Results
3.1. Descriptive statistics and data analyses
Table 1 provides the means, standard deviations and zero-
order correlations for all dependent variables. A few things are
noteworthy. First, baseline measures of attachment anxiety
and attachment avoidance are unrelated to treatment (see
Table 1). Second, whereas attachment anxiety is not related to
trust and cooperation, attachment avoidance is-higher attach-
ment avoidance negatively relates to cooperation, trust, and
feeling at ease; attachment avoidance positively relates to
betrayal aversion and hostility. Third, treatment is unrelated
to any of the dependent variables, which fits the recent insight
that effects of oxytocin depend on context and person (Bartz
et al., 2011). Fourth, cooperation and trust are not related
to affiliation tendencies, but strongly related to betrayal
aversion. Accordingly, only betrayal aversion qualifies as a
potential mediator of hypothesized treatment  attachment
avoidance interactions on cooperation (as predicted in
Hypothesis 3a; Baron and Kenny, 1986).
Hypotheses were tested with moderated multiple regres-
sions. Predictors were Attachment Anxiety, Attachment
Avoidance (both mean centered), Treatment (dummy coded:
0 = placebo; 1 = oxytocin), and all possible two-way and three-
way interactions. Significant interactions involving treatment
were interpreted in two ways. First, regression models were
computed with reverse-coded dummy for treatment (i.e.,
0 = oxytocin; 1 = placebo), the logic being that main effects
for attachment anxiety and/or attachment avoidance reflect
an effect under placebo, and in the reverse-coded dummy
regressions reflect an effect under oxytocin (Aiken and West,
1991). Second, simple slopes at 1SD for attachment avoidance
(and attachment anxiety where relevant) were estimated. All
hypotheses were tested at p < 0.05 (two-tailed).
3.2. Cooperation, trust, and betrayal aversion
In a first set of regressions, cooperation, trust, and betrayal
aversion served as dependent variables. Table 2 summarizes
Table 2 Regression of cooperation, trust, and betrayal aversion on attachment anxiety (anxious), attachment avoidance
(avoidant), treatment, and their interactions.
Predictors Dependent variables
Cooperation B (SE) Trust B (SE) Betrayal aversion B (SE)
Anxiousa 0.136 (0.398) 0.152 (0.325) 0.006 (0.363)
Avoidanta 1.155 (0.409) ** 1.368 (0.333) ** 1.322 (0.373) **
Treatmentb 0.045 (0.286) 0.347 (0.233) 0.314 (0.261)
Anxious  Avoidant 0.291(0.798) 0.540 (0.651) 0.857 (0.728)
Anxious  Treatment 0.324 (0.514) 0.139 (0.419) 0.214 (0.469)
Avoidant  Treatment 1.546 (0.578) ** 1.625 (0.471) ** 1.370 (0.527) **
Anxious  Avoidant  Treatment 0.619 (1.054) 0.415 (0.859) 0.201 (0.961)
R (F[7,70]) 0.384 (1.89)# 0.482 (3.023) ** 0.417 (2.11) *
a Attachment anxiety and avoidance are coded from low (1) to high (5).
b Treatment is dummy coded with 0 = placebo and 1 = oxytocin.
# p < .10 (two-tailed, with N = 77).
* p < .05 (two-tailed, with N = 77).
























































Figure 1 (A) Oxytocin leads to more cooperation than placebo
among individuals high (+1SD) but not low (1SD) in attachment
avoidance. (B) Oxytocin leads to more trust than placebo among
individuals high (+1SD) but not low (1SD) in attachment avoid-
ance. (C) Oxytocin leads to less betrayal aversion than placebo
among individuals high (+1SD) but not low (1SD) in attachment
avoidance.
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Avoidance  Treatment effect for cooperation. The main
effect for Attachment Avoidance was significant too,
B = 1.155, SE = 0.408, t = 2.828, p < 0.006, indicating
that when males were given placebo, those lower in attach-
ment avoidance more often cooperated than those higher in
attachment avoidance. A regression with reversed dummy
coding for Treatment showed no effect for attachment avoid-
ance when males received oxytocin, B = 0.390, SE = 0.408,
t = 0.955, p < 0.343. Put differently, participants with low
attachment avoidance (1SD) cooperated somewhat less
when given oxytocin rather than placebo, B = 0.774,
SE = 0.413, t = 1.874, p < 0.10; participants with high
attachment avoidance (+1SD) cooperated significantly more
when given oxytocin rather than placebo, B = 0.864,
SE = 0.424, t = 2.037, p < 0.045 (see also Fig. 1A). This con-
firms Hypothesis 1.
With regard to trust, a similar pattern of results emerged.
Table 2 shows a significant Attachment Avoidance  Treat-
Treatment effect for trust, with a main effect for Attach-
ment Avoidance, B = 1.368, SE = 0.333, t = 4.107,
p < 0.001, indicating that when males were given placebo,
those lower in attachment avoidance reported more trust
than those higher in attachment avoidance. A regression with
reversed dummy coding for Treatment showed no effect for
attachment avoidance when males received oxytocin,
B = 0.257, SE = 0.333, t = 0.772, p < 0.443. Put differently,
participants with low attachment avoidance (1SD) showed
no effect of treatment, B = 0.515, SE = 0.337, t = 1.527,
p < 0.131; participants with high attachment avoidance
(+1SD) reported more trust when given oxytocin rather than
placebo, B = 1.208, SE = 0.346, t = 3.493, p < 0.001 (see also
Fig. 1B). This confirms Hypothesis 2a.
For betrayal aversion, results showed a significant Attach-
ment Avoidance  Treatment interaction (see Table 2). The
significant main effect for attachment avoidance in this
model indicates that under placebo, males with lower
attachment avoidance had lower betrayal aversion than
those with higher attachment avoidance, B = 1.323,
SE = 0.373, t = 3.546, p < 0.001. A regression with reversed
dummy coding for treatment showed no effect for
Table 3 Regression of affiliation tendencies, betrayal aversion, and feeling at ease on attachment anxiety (anxious), attachment
avoidance (avoidant), treatment, and their interactions.
Predictors Dependent variables
Affiliation B (SE) Feeling at ease B (SE)
Anxiousa 0.496 (0.226) * 0.121 (0.165)
Avoidanta 0.114 (0.285) 0.157 (0.169)
Treatmentb 0.229 (0.199) 0.199 (0.118)#
Anxious  Avoidant 1.157 (0.480) ** 0.139 (0.330)
Anxious  Treatment 0.528 (0.358) 0.476 (0.213) **
Avoidant  Treatment 0.204 (0.402) 0.794 (0.239) **
Anxious  Avoidant  Treatment 0.911 (0.734) 0.426 (0.436)
R (F[7,70]) 0.335 (1.263) 0.521 (3.721) **
a Attachment anxiety and avoidance are coded from low (1) to high (5).
b Treatment is dummy coded with 0 = placebo and 1 = oxytocin.
# p < .10 (two-tailed, with N = 77).
* p < .05 (two-tailed, with N = 77).
** p < .025 (two-tailed, with N = 77).
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B = 0.048, SE = 0.373, t = 0.129, p < 0.897. Put differ-
ently, participants with low attachment avoidance (1SD)
showed no effect for treatment, B = 0.412, SE = 0.337,
t = 1.093, p < 0.278; participants with high attachment
avoidance (+1SD) showed lower betrayal aversion when given
oxytocin rather than placebo, B = 1.040, SE = 0.387,
t = 2.687, p < 0.009 (see Fig. 1C). This confirms Hypothesis
2a.
Because of its patterning, betrayal aversion qualifies as a
possible mediator between attachment avoidance and treat-
ment on the one hand, and cooperation on the other. Indeed,
betrayal aversion correlated with cooperation (see Table 1),
and a regression with cooperation as dependent, and
betrayal aversion as control variable showed a significant
reduction in explained variance for cooperation compared to
the model in which betrayal aversion was not controlled for,
Sobel Z = 2.222, p < 0.0262. Specifically, when controlling
for betrayal aversion, the Attachment Avoidance  Treat-
Treatment interaction on cooperation is no longer signifi-
cant, B = 0.844, SE = 0.539, t = 1.567, p < 0.122, the main
effect for attachment avoidance also drops to non-signifi-
cance, B = 0.479, SE = 0.395, t = 1.211, p < 0.230, and
the main effect for betrayal aversion is significant,
B = 0.512, SE = 0.117, t = 4.389, p < 0.001. This confirms
Hypothesis 3a.
Taken together, results confirm Hypotheses 1, 2a, and 3a.
When given placebo, males with lower attachment avoidance
reported more trust and reduced betrayal aversion, and
therefore cooperated more often than males with higher
attachment avoidance; when given oxytocin, attachment
avoidance no longer associated with trust, betrayal aversion,
and cooperation.
3.3. Affiliation and post-task mood
In a second set of regressions, affiliation and post-task mood
states (feeling at ease, happiness, hostility) served as depen-
dent variables. For hostility, no effects were significant (all
t < 0.981, all p > 0.327). For happiness, results only showed
a three-way interaction among attachment anxiety,attachment avoidance, and treatment, B = 1.732,
SE = 0.621, t = 2.790, p < 0.01. Follow-up analyses revealed
no lower order effects whatsoever (all t < 1.301, all
p > 0.192), prohibiting an interpretation of this unantici-
pated and complex effect.
Table 3 summarizes the results for affiliation and feeling at
ease. With regard to affiliation (Hypothesis 1b), results
showed an unanticipated main effect for Attachment Anxi-
ety, qualified by an Attachment Anxiety  Attachment Avoid-
ance interaction. Simple slopes analyses at 1SD of
attachment avoidance showed no relationship between
attachment anxiety and affiliation among participants with
high attachment avoidance, B = 0.117, SE = 0.237, t = 0.429,
p < 0.669; among participants low in attachment avoidance,
however, attachment anxiety negatively predicted affiliation
tendencies, B = 1.109, SE = 0.396, t = 2.799, p < 0.007.
Because treatment did not interact with attachment avoid-
ance in predicting affiliation tendencies, affiliation does not
qualify as a possible mediator between attachment avoid-
ance and treatment on the one hand, and cooperation on the
other. Indeed, a regression with cooperation as dependent,
and affiliation tendencies as control variable showed no
significant reduction in explained variance for cooperation
compared to the model in which affiliation was not controlled
for, Sobel Z = 0.18, p < 0.772. Both Hypothesis 1b and
Hypothesis 3b need to be rejected.
With regard to feeling at ease, results showed significant
Attachment Anxiety  Treatment, and Attachment Avoidan-
ce  Treatment interactions (see Table 3). Under placebo,
main effects for attachment anxiety, and attachment avoid-
ance, indicated that participants with lower attachment
anxiety and/or attachment avoidance felt more at ease than
those with higher attachment anxiety and/or attachment
avoidance (see Table 3). A regression with reversed dummy
coding for Treatment showed no main effects for attachment
anxiety, B = 0.121, SE = 0.165, t = 0.731, p < 0.468, or for
attachment avoidance, B = 0.157, SE = 0.169, t = 0.931,
p < 0.355, when males received oxytocin. Put differently,
participants with low attachment avoidance (1SD) showed
no effect for treatment, B = 0.222, SE = 0.176, t = 1.263,
p < 0.221; participants with high attachment avoidance
Figure 2 (A) Oxytocin leads to stronger feeling at ease than
placebo among individuals high (+1SD) but not low (1SD) in
attachment avoidance. (B) Oxytocin leads individuals to select
secure attachment scenarios more, and insecure attachment
scenarios less, than placebo.
Oxytocin modulates the link between adult attachment and cooperation 877(+1SD) felt more at ease when given oxytocin rather than
placebo, B = 0.619, SE = 0.171, t = 3.620, p < 0.001 (see
Fig. 2A).4
3.4. Feelings of attachment
The results for feeling at ease fit earlier studies showing that
oxytocin modulates feelings of attachment (Buchheim et al.,
2009; Bartz et al., 2010a). Indeed, tabulating participant
choices for the Hazan and Shaver (1987; HS) measure of
attachment given at the end of experiment, showed that
more participants given oxytocin rather than placebo chose
HS-Secure, and fewer participants given oxytocin chose the
HS-Anxious or HS-Avoidant, x2 (1, N = 77) = 4.741, p < 0.030
(see Fig. 2B). Thus, oxytocin increases feeling at ease espe-
cially among individuals with higher attachment avoidance,
and directly improves feelings of secure attachment.4 Because of its patterning, feeling at ease qualifies as a possible
mediator between attachment avoidance and treatment on the one
hand, and cooperation on the other. However, feeling at ease did not
correlate with cooperation (see Table 1). A regression analysis with
cooperation as dependent variable and feeling at ease as control
variable revealed virtually no change in explained variance in coop-
eration compared to the model in which feeling at ease was not
controlled for, Sobel Z = 0.377, p < 0.547. From this it follows that
feeling at ease does not mediate the effects of attachment avoid-
ance and treatment on cooperation.4. Conclusions and discussion
To survive and prosper in interpersonal encounters, humans
need to detect whether unknown protagonists are trust-
worthy and likely to reciprocate cooperative effort or,
instead, are untrustworthy and likely to exploit others. To
predict others’ behavioral tendencies, humans rely on cog-
nitive-emotional schemas that are formed across the lifespan
and position the individual on two broad dimensions of
attachment — attachment anxiety, and attachment avoid-
ance. Especially attachment avoidance is relevant here, as it
typically associates with representations of others as essen-
tially untrustworthy, undependable, and unreliable (Bowlby,
1973; Mikulincer and Shaver, 2007). Indeed, the current
experiment showed that healthy males scoring high rather
than low on attachment avoidance trusted less an unknown
protagonist, feared betrayal more, and less often decided to
approach their protagonist cooperatively. Importantly, how-
ever, these effects of attachment avoidance disappeared
when males received, prior to decision-making, intranasal
oxytocin rather than placebo. Especially those high in attach-
ment avoidance had higher trust, lower betrayal aversion,
and they cooperated more when given oxytocin rather than
placebo.
There are three possible explanations for these findings.
First, the availability of oxytocin in the brain may promote
affiliation tendencies and as individuals high in attachment
avoidance are chronically low in affiliation tendencies, it is
especially them who benefit from exogenous oxytocin. This
possibility was, however, not supported in the current experi-
ment-oxytocin did not interact with attachment avoidance in
predicting affiliation tendencies (e.g., desire for future
interaction) and affiliation did not statistically mediate
effects of oxytocin and attachment avoidance on coopera-
tion. Second, the availability of oxytocin may reduce general
feelings of fear and distress (Heinrichs et al., 2008), and this
could affect especially individuals high rather than low in
attachment avoidance (and attachment anxiety) (Buchheim
et al., 2009). Lowered fear and distress allows individuals to
consider other behavioral strategies than ‘‘fight-or-flight,’’
and thus creates room for cooperative approach. This pos-
sibility is unlikely because (i) it is difficult to see why this
process operates for attachment avoidance but not for
attachment anxiety, and attachment anxiety did not relate
to trust, betrayal aversion, and cooperation (see also below);
and (ii) attachment avoidance and oxytocin interacted to
predict feeling at ease, yet feeling at ease did not statisti-
cally mediate between attachment avoidance and oxytocin
on the one hand, and cooperation on the other.
The third possible explanation proceeds on the basis of the
assumption that the availability of oxytocin in the brain alters
cognitive-emotional schemas of others as untrustworthy,
undependable, and unreliable into more benevolent views
of others (Bartz et al., 2011). Indeed, intranasal oxytocin
makes people less aversive of angry faces (Evans et al.,
2010), more likely to accept allies displaying high — rather
than low threat (De Dreu et al., 2011b), it de-activates neural
circuitries associated with betrayal aversion (Baumgartner
et al., 2008), increases perceived facial trustworthiness
and attractiveness (Theodoridou et al., 2009), and activates
neural circuitries associated with empathy such as the
inferior frontal gyrus and the ventromedial prefrontal cortex
878 C.K.W. De Dreu(Riem et al., 2011; Shamay-Tsoory, 2011). Because it is espe-
cially individuals high in attachment avoidance who act on
those negative scripts, it is especially them who might benefit
from exogenous oxytocin. This possibility received some sup-
port in the current experiment-oxytocin interacted with
attachment avoidance to predict trust and betrayal aversion,
and betrayal aversion statistically mediated effects of oxyto-
cin and attachment avoidance on cooperation. Further support
for this possible explanation would come from new research
showing that oxytocin interacts with attachment avoidance in
altering the neural circuitries involved in, and the cognitive
schemas used in person perception and impression formation
(e.g., Amodio and Frith, 2006).
Attachment avoidance provides a model of others’
dependability and trustworthiness, and interacted here with
oxytocin in predicting trust and cooperation. Attachment
anxiety provides a model of the self as being unworthy of
others’ love and generosity, and did not interact here with
oxytocin in predicting trust and cooperation. Other studies
did, however, observe meaningful interactions between oxy-
tocin and attachment anxiety. For example, Bartz et al.
(2010a) found that intranasal oxytocin increased benevolent
recollections of maternal care among individuals low in
attachment anxiety, and negative recollections among indi-
viduals high in attachment anxiety. In another study, Bartz
et al. (2010b) observed that especially among individuals
high in attachment anxiety, oxytocin increased trust in a
cooperative protagonist among individuals low in attachment
avoidance, yet decreased trust in a cooperative protagonist
among individuals high in attachment avoidance.
Whereas in the current study, the protagonist was
unknown and no feedback about his behavioral choices were
provided, in those studies showing interactions among
attachment anxiety and oxytocin, such information was
available-participants were thinking about their mother’s
availability (Bartz et al., 2010a), or were provided with
feedback showing their protagonist cooperated on previous
rounds of the decision making game (Bartz et al., 2010b).
Whereas in the current study, participants’ main task was to
predict what their unknown protagonist might do, partici-
pants in the Bartz et al. studies at least also had to interpret
and make sense of the target’s behavior. Seen this way, one
may speculate that oxytocin interacts with attachment
avoidance primarily in altering mental models of others, thus
affecting feelings of dependency and estimates of others’
trustworthiness. Similarly, one may speculate that oxytocin
interacts with attachment anxiety primarily in altering the
interpretation of others’ behavioral tendencies, such that
potentially ambivalent behavior is interpreted more posi-
tively among low attachment anxiety individuals given oxy-
tocin, and more negatively among high attachment
individuals given oxytocin.
That oxytocin modulates prediction among individuals
high in attachment avoidance, and interpretation and
sense-making among individuals high in attachment anxiety,
fits the results of recent neuro-imaging studies. These
showed that when one’s protagonist cooperated, oxytocin
increased the caudate nucleus response, and this may facil-
itate the learning that another person can be trusted (Rilling
et al., 2011). Future research could test the hypothesis that
this effect emerges especially among individuals high rather
than low in attachment anxiety, and is not contingent uponattachment avoidance. The other way around, that oxytocin
modulates prediction especially among individuals high
rather than low in attachment avoidance fits the finding that
oxytocin reduces amygdala activity and attenuated its cou-
pling to brainstem centers responsible for autonomic and
behavioral components of fear (Kirsch et al., 2005; Petrovic
et al., 2008; also see Baumgartner et al., 2008). Future
research could test the hypothesis that these effects emerge
especially among individuals high rather than low in attach-
ment avoidance, and are not contingent upon attachment
anxiety.
The use of neuropeptide administration permits conclu-
sions about the causal effects of oxytocin, thus complement-
ing studies showing that blood plasma oxytocin correlates
with feelings of attachment (e.g., Tops et al., 2007; Marazziti
et al., 2009; Strathearn et al., 2009) and/or attachment-
related thoughts and behaviors (Feldman et al., 2007, 2010;
Gordon et al., 2010). Whereas neuropeptide administration
provides unequivocal evidence that the availability of brain
oxytocin moderates the relationship between attachment
avoidance and cooperative cognition and behavior, correla-
tional studies allow for reverse causality — that cooperative
cognition and behavior interacts with feelings of attachment
to predict levels of peripheral and/or central oxytocin.
Indeed, in postmenopausal women, elevated plasma oxyto-
cin significantly associates with gaps in social relationships,
with less positive relationships with a primary partner, and
with elevated cortisol levels (Taylor et al., 2006), and Mar-
azziti et al. (2009) observed a positive correlation between
attachment anxiety in close relationships and blood plasma
oxytocin. Possibly then, stress and rejection-related
thoughts are physiologically down-regulated by hypothala-
mic release of oxytocin, allowing the individual to respond to
stressful events — including interaction with unknown others
— in more constructive manners than through immediate
fight-or-fly (Taylor et al., 2000; Taylor, 2006).
Current results show that enhanced availability of oxyto-
cin in the brain increases constructive approach among
individuals high more than among those low in attachment
avoidance. Together with the finding that stress is down-
regulated by oxytocin release, this suggests the intriguing
possibility that neural circuitries in individuals high in attach-
ment avoidance not necessarily respond differentially to
oxytocin release than those low in attachment avoidance.
Instead, current findings suggest that it is the hypothalamic
production of oxytocin that is differentially regulated in
individuals high rather than low in attachment avoidance.
This question requires new research, that could then
also examine whether individuals high in attachment avoid-
ance have relatively low oxytocin release in general, or
whether their oxytocin release is triggered by different
contexts than oxytocin release in individuals low in attach-
ment avoidance.
Notwithstanding these and related questions for new
research, current findings subscribe to the emerging insight
that there is an intimate and reciprocal connection between
neurobiological circuitries and life-span development of
chronic individual differences in affiliation and social
approach tendencies (Depue and Morrone-Strupinsky,
2005). Oxytocin is a critical mediator between parenting
behaviors and the development of infant attachment (Feld-
man et al., 2007, 2010; Gordon et al., 2010), that through
Oxytocin modulates the link between adult attachment and cooperation 879social interactions are reinforced as children mature into
adults (Bowlby, 1973; Mikulincer and Shaver, 2007). In adults,
exogenous oxytocin increases feelings of secure attachment
(Buchheim et al., 2009), and among those high in attachment
avoidance, elevating oxytocin reduces betrayal aversion and
increases trust and cooperation (current findings). Impor-
tantly, higher rates of cooperation are potentially rewarding
and stimulating long-term constructive exchange-as a result
of treatment with oxytocin, high attachment avoidance
individuals engage in a constructive and potentially mutually
rewarding exchange, and this in itself may facilitate the
development of stronger social bonds, generalized trust
and, perhaps, secure attachment. Oxytocin not only med-
iates parent—child bonding and the development of infant
attachment. Among adults lacking secure attachment, oxy-
tocin reduces fear and betrayal aversion, and facilitates the
development of trust and constructive social exchange.
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